Scribe Therapeutics Announces Oral Presentation at 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
ALAMEDA, Calif.--(BUSINESS WIRE)-- #CRISPR--Data on Scribe’s X-Editor technologies validates the high activity, specificity and deliverability achievable through CRISPR by Design™
